Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
Breast cancer consists of at least five main molecular “intrinsic” subtypes that are reflected in both pre-invasive and invasive disease. Although previous studies have suggested that many of the molecular features of invasive breast cancer are established early, it is unclear what mechanisms drive...
| Published in: | Cell Reports |
|---|---|
| Main Authors: | Robert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, Valeria Vitelli, Torill Sauer, Jürgen Geisler, Solveig Hofvind, Elin Borgen, Anne-Lise Børresen-Dale, Olav Engebråten, Øystein Fodstad, Øystein Garred, Gry Aarum Geitvik, Rolf Kåresen, Bjørn Naume, Gunhild Mari Mælandsmo, Hege G. Russnes, Ellen Schlichting, Therese Sørlie, Ole Christian Lingjærde, Vessela Kristensen, Kristine Kleivi Sahlberg, Helle Kristine Skjerven, Britt Fritzman |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-07-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124716308051 |
Similar Items
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
by: Aldema Sas‐Chen, et al.
Published: (2016-08-01)
by: Aldema Sas‐Chen, et al.
Published: (2016-08-01)
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes
by: Wanja Kildal, et al.
Published: (2024-07-01)
by: Wanja Kildal, et al.
Published: (2024-07-01)
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.
by: Miriam Ragle Aure, et al.
Published: (2013-01-01)
by: Miriam Ragle Aure, et al.
Published: (2013-01-01)
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
by: Evita Maria Lindholm, et al.
Published: (2019-10-01)
by: Evita Maria Lindholm, et al.
Published: (2019-10-01)
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
by: Mari Tinholt, et al.
Published: (2020-01-01)
by: Mari Tinholt, et al.
Published: (2020-01-01)
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.
by: Lisa Svartdal Normann, et al.
Published: (2023-01-01)
by: Lisa Svartdal Normann, et al.
Published: (2023-01-01)
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
by: Andreas Hagen Røssevold, et al.
Published: (2025-06-01)
by: Andreas Hagen Røssevold, et al.
Published: (2025-06-01)
The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.
by: Laxmi Silwal-Pandit, et al.
Published: (2015-01-01)
by: Laxmi Silwal-Pandit, et al.
Published: (2015-01-01)
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
by: Solveig Pettersen, et al.
Published: (2023-02-01)
by: Solveig Pettersen, et al.
Published: (2023-02-01)
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials
by: Nikolai Kragøe Andresen, et al.
Published: (2025-07-01)
by: Nikolai Kragøe Andresen, et al.
Published: (2025-07-01)
B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses
by: Helga Bergholtz, et al.
Published: (2025-03-01)
by: Helga Bergholtz, et al.
Published: (2025-03-01)
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.
by: Karianne Risberg, et al.
Published: (2011-01-01)
by: Karianne Risberg, et al.
Published: (2011-01-01)
Data integration from two microarray platforms identifies bi-allelic genetic inactivation of <it>RIC8A </it>in a breast cancer cell line
by: Kleivi Kristine, et al.
Published: (2009-05-01)
by: Kleivi Kristine, et al.
Published: (2009-05-01)
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
by: Ragnhild Sørum Falk, et al.
Published: (2024-01-01)
by: Ragnhild Sørum Falk, et al.
Published: (2024-01-01)
Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes
by: Marit Otterlei Fjørtoft, et al.
Published: (2025-05-01)
by: Marit Otterlei Fjørtoft, et al.
Published: (2025-05-01)
Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients
by: Borresen-Dale Anne-Lise, et al.
Published: (2011-04-01)
by: Borresen-Dale Anne-Lise, et al.
Published: (2011-04-01)
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
by: Nina Gran Egeland, et al.
Published: (2020-05-01)
by: Nina Gran Egeland, et al.
Published: (2020-05-01)
Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
by: Ane Kongsgaard, et al.
Published: (2016-06-01)
by: Ane Kongsgaard, et al.
Published: (2016-06-01)
Lydens magi
by: Jon Sverre Thorstensen, et al.
Published: (2024-09-01)
by: Jon Sverre Thorstensen, et al.
Published: (2024-09-01)
Lydens magi
by: Jon Sverre Thorstensen, et al.
Published: (2024-09-01)
by: Jon Sverre Thorstensen, et al.
Published: (2024-09-01)
Developing the HLS19-YP12 for measuring health literacy in young people: a latent trait analysis using Rasch modelling and confirmatory factor analysis
by: Christopher Le, et al.
Published: (2022-12-01)
by: Christopher Le, et al.
Published: (2022-12-01)
Understanding Patterns of the Gut Microbiome May Contribute to the Early Detection and Prevention of Type 2 Diabetes Mellitus: A Systematic Review
by: Natalia G. Bednarska, et al.
Published: (2025-01-01)
by: Natalia G. Bednarska, et al.
Published: (2025-01-01)
The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma
by: Caroline E. Nunes-Xavier, et al.
Published: (2023-05-01)
by: Caroline E. Nunes-Xavier, et al.
Published: (2023-05-01)
Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma
by: Caroline E. Nunes‑Xavier, et al.
Published: (2023-06-01)
by: Caroline E. Nunes‑Xavier, et al.
Published: (2023-06-01)
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
by: Ayechew Adera Getu, et al.
Published: (2023-03-01)
by: Ayechew Adera Getu, et al.
Published: (2023-03-01)
Metaphysical Grounding and Being’s Incompleteness
by: Fritzman, J.M.
Published: (2024-12-01)
by: Fritzman, J.M.
Published: (2024-12-01)
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array.
by: Bin Wang, et al.
Published: (2011-01-01)
by: Bin Wang, et al.
Published: (2011-01-01)
Ultrasound visualization and blood flow velocity measurements of the adrenal arteries in the fetus
by: Øystein Bergøy, et al.
Published: (2025-01-01)
by: Øystein Bergøy, et al.
Published: (2025-01-01)
Participation and engagement in online cognitive testing
by: Daniel Radosław Sokołowski, et al.
Published: (2024-06-01)
by: Daniel Radosław Sokołowski, et al.
Published: (2024-06-01)
The incidence of late-detected developmental dysplasia of the hip and its functional outcomes: a 17-year cohort study using selective ultrasound screening
by: Øyvind Håberg, et al.
Published: (2023-12-01)
by: Øyvind Håberg, et al.
Published: (2023-12-01)
Hvorfor finnes ikke norsk feministisk kunsthistorie?
by: Øystein Sjåstad
Published: (2021-01-01)
by: Øystein Sjåstad
Published: (2021-01-01)
„Wszyscy jesteśmy włóczęgami na Ziemi...”
by: Øystein Rottem
Published: (2002-12-01)
by: Øystein Rottem
Published: (2002-12-01)
Edvard Diriks: En viking på Montparnasse
by: Øystein Sjåstad
Published: (2018-01-01)
by: Øystein Sjåstad
Published: (2018-01-01)
Hva jenter må vite: Kristiane Skjerve, Sundhetslæren og jenters seksualitet
by: Øystein Skundberg
Published: (2018-01-01)
by: Øystein Skundberg
Published: (2018-01-01)
Tøvær: Munch, landskap og Elgersburg-kvintetten
by: Øystein Ustvedt
Published: (2019-01-01)
by: Øystein Ustvedt
Published: (2019-01-01)
Annette Rosenvold Hvidt,Gertrud Oelsner: Vilhelm Hammershøi. På sporet av det åbne billede
by: Øystein Sjåstad
Published: (2019-01-01)
by: Øystein Sjåstad
Published: (2019-01-01)
Faunal remains from Mediaeval Bergen
by: Øystein Wiig
Published: (1981-12-01)
by: Øystein Wiig
Published: (1981-12-01)
Change in the degree of infestation of parasitic nematodes in Grey Seals Halichoerus grypus from Froan, Norway
by: Øystein Wiig
Published: (1988-12-01)
by: Øystein Wiig
Published: (1988-12-01)
The Grey Seal Halichoerus grypus (Fabricius) and the Common Seal Phoca vitulina L. in Lofoten and Vesterålen, northern Norway
by: Øystein Wiig
Published: (1989-12-01)
by: Øystein Wiig
Published: (1989-12-01)
Lovbrudd i næring
by: Øystein Gjelsvik
Published: (1954-06-01)
by: Øystein Gjelsvik
Published: (1954-06-01)
Similar Items
-
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
by: Aldema Sas‐Chen, et al.
Published: (2016-08-01) -
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes
by: Wanja Kildal, et al.
Published: (2024-07-01) -
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.
by: Miriam Ragle Aure, et al.
Published: (2013-01-01) -
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
by: Evita Maria Lindholm, et al.
Published: (2019-10-01) -
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
by: Mari Tinholt, et al.
Published: (2020-01-01)
